122 related articles for article (PubMed ID: 19187189)
1. HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.
Denholm JT; Wright EJ; Street A; Sasadeusz JJ
Haemophilia; 2009 Mar; 15(2):538-43. PubMed ID: 19187189
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.
Posthouwer D; Mauser-Bunschoten EP; Fischer K; Makris M
Haemophilia; 2006 Sep; 12(5):473-8. PubMed ID: 16919076
[TBL] [Abstract][Full Text] [Related]
3. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
4. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.
Quarleri JF; Bolcic FM; Bouzas MB; Laufer N; Gómez Carrillo M; Mammana L; Kaufman S; Pérez H; Cahn P; Salomon H
Acta Gastroenterol Latinoam; 2007 Jun; 37(2):76-83. PubMed ID: 17684937
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of induction therapy with high-dose interferon for patients with hemophilia and human immunodeficiency virus-hepatitis C virus coinfection.
Hanabusa H
Clin Infect Dis; 2002 Dec; 35(12):1527-33. PubMed ID: 12471573
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia.
Goedert JJ; Brown DL; Hoots K; Sherman KE
Haemophilia; 2004 Oct; 10 Suppl 4():205-10. PubMed ID: 15479399
[TBL] [Abstract][Full Text] [Related]
7. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
8. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
Inglot M; Szymczak A; Gasiorowski J
Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
[TBL] [Abstract][Full Text] [Related]
9. Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
Gatti F; Nasta P; Matti A; Manno D; Mendeni M; Puoti M; Carosi G
AIDS Rev; 2007; 9(1):16-24. PubMed ID: 17474310
[TBL] [Abstract][Full Text] [Related]
10. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
11. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
[TBL] [Abstract][Full Text] [Related]
14. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.
Cacoub P; Halfon P; Rosenthal E; Pialoux G; Benhamou Y; Perronne C; Pol S;
J Hepatol; 2008 Jan; 48(1):35-42. PubMed ID: 17945375
[TBL] [Abstract][Full Text] [Related]
16. The effect of controlled therapy interruption in chronic HCV infection: enhanced host immune response? A hypothesis.
Lake-Bakaar G
J Clin Virol; 2009 Feb; 44(2):149-51. PubMed ID: 19157972
[TBL] [Abstract][Full Text] [Related]
17. When to treat and the benefits of treating hepatitis C in patients with haemophilia.
Patel H; Heathcote EJ
Haemophilia; 2009 Jan; 15(1):20-32. PubMed ID: 18976253
[TBL] [Abstract][Full Text] [Related]
18. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study.
Omland LH; Jepsen P; Skinhøj P; Jørgensen HL; Münster AM; Bangsborg J; Fenger M; Sørensen HT; Obel N
HIV Med; 2009 Feb; 10(2):65-71. PubMed ID: 19018878
[TBL] [Abstract][Full Text] [Related]
19. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Wedemeyer H; Schuller E; Schlaphoff V; Stauber RE; Wiegand J; Schiefke I; Firbas C; Jilma B; Thursz M; Zeuzem S; Hofmann WP; Hinrichsen H; Tauber E; Manns MP; Klade CS
Vaccine; 2009 Aug; 27(37):5142-51. PubMed ID: 19559112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
